1.A consensus of key opinion leaders on the management of pre-diabetes in the Asia-Pacific region.
Roberto MIRASOL ; Ah Chuan THAI ; Aftab Ahmad SALAHUDDIN ; Kathryn TAN ; Chaicharn DEEROCHANAWONG ; Mafauzy MOHAMED ; Made Ratna SARASWATI ; Bipin Kumar SETHI ; Sanjiv SHAH ; Nanny Natalia SOETEDJO ; Swangjit SURAAMORNKUL ; Rima TAN ; Farid UDDIN
Journal of the ASEAN Federation of Endocrine Societies 2017;32(1):6-12
The Asia-Pacific region carries a high disease burden, with over half of the global diabetic population residing in this region. Increasing evidence shows that without targeted intervention, the progression from impaired glucose tolerance (IGT) to type 2 diabetes occurs more frequently in Asians compared with Caucasians. Furthermore, IGT is independently associated with an increased risk of cardiovascular disease, and should be managed as early as possible. Because diabetes is now a major public health issue, strategies aimed at prevention and treatment are urgently required. Lifestyle modification, including weight loss, dietary changes and increased physical activity, play a major role in controlling the disease. Significant evidence also supports the effectiveness of a combination of lifestyle modification and pharmacologic therapy, such as metformin, in delaying the onset of diabetes. Although the importance of lifestyle interventions is well recognized throughout Asia, many countries do not have formal recommendations to guide the diagnosis and management of individuals at risk of progression to diabetes. At a recent regional meeting, experts from the Asian region convened to develop consensus recommendations to guide clinicians in the management of Asian patients with pre-diabetes. These consensus recommendations provide a clear and concise approach to the management of individuals with IGT based on the available evidence and current best clinical practice.
Human ; Male ; Female ; Adult ; Prediabetic State ; Asia
2.A consensus of key opinion leaders on the management of pre-diabetes in the Asia-Pacific Region
Roberto Mirasol ; Ah Chuan Thai ; Aftab Ahmad Salahuddin ; Kathryn Tan ; Chaicharn Deerochanawong ; Mafauzy Mohamed ; Made Ratna Saraswati ; Bipin Kumar Sethi ; Sanjiv Shah ; Nanny Natalia Soetedjo ; Swangjit Suraamornkul ; Rima Tan ; Farid Uddin
Journal of the ASEAN Federation of Endocrine Societies 2016;31(11):6-12
		                        		
		                        			
		                        			The  Asia-Pacific  region  carries  a  high disease  burden,  with  over  half of    the  global  diabetic  population  residing  in   thisregion. Increasing evidence shows that without targeted intervention, the progression from impaired glucose tolerance(IGT) to   type  2  diabetes occurs  more  frequently  in   Asians  compared  with  Caucasians.  Furthermore,  IGT  is  independently  associated  with  an  increased  risk  of    cardiovascular  disease,  and  should  be  managed  as    early  as   possible.  Because  diabetes  is   now  a  major  public  health  issue,    strategies  aimed  at    prevention  and  treatment  areurgently required. Lifestyle modification, including weight loss, dietary changes and increased physical activity, play a major role in  controlling the disease. Significant evidence also supports the effectiveness of   a combination of   lifestylemodification and pharmacologic therapy, such as   metformin, in  delaying the onset of   diabetes. Although the importanceof    lifestyle  interventions  is   well  recognized  throughout  Asia,  many  countries  do  not  have  formal  recommendations  to  guide  the  diagnosis  and  management  of    individuals  at    risk  of    progression  to   diabetes.  At    a  recent  regional  meeting,experts   from   the   Asian   region   convened   to    develop   consensus   recommendations   to    guide   clinicians   in    themanagement  of    Asian  patientswith  pre-diabetes.  These  consensus  recommendations  provide  a  clear  and  conciseapproach to  the management of   individuals with IGT based on   the available evidence and current best clinical practice.
		                        		
		                        		
		                        		
		                        			Glucose Intolerance
		                        			;
		                        		
		                        			 Asia 
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail